Potent-powder containment for pharmaceutical dispensing and blending: sized to the compound's exposure limit, proven with surrogate powder

01

Same band name, different numbers: OEB 4 is 1–10 µg/m³ in one scheme and ≤0.05 µg/m³ in another

Occupational exposure bands give a concentration range for compounds without enough data for a firm limit, and the published schemes do not line up. Authors from Pfizer and the University of Adelaide reproduce a scheme adapted from Graham et al.; Genentech toxicologists state that banding systems are not harmonised across the industry and use Roche/Genentech's own ranges. [1] [2]

Genentech's authors estimated exposure limits for 83 oral FDA-approved small-molecule kinase inhibitors, ranging from 0.05 to 96 µg/m³ with 82% between 1 and <100 µg/m³, and concluded that a default band of 1–<10 µg/m³ (their OEB 3A) is “likely protective for most SMKIs” in data-limited development, with lower estimated limits for families such as JAK, FGFR, MEK, mTOR, PI3K and VEGFR inhibitors. [2]

Editorial calculation: the bottom of OEB 4 in the first scheme (1 µg/m³) is 20 times the top of OEB 4 in the Roche/Genentech scheme (0.05 µg/m³). A request for 'OEB 4 containment' can therefore mean targets twenty times apart or more; state the number in µg/m³ and the averaging time instead of the band name.

Give the containment supplier the compound's occupational exposure limit or band range in µg/m³ (8-hour time-weighted average), the banding scheme it comes from, the quantities handled per operation and the operations involved (dispensing, charging, sampling, discharging, cleaning).

02

Closed transfers between container and process: split butterfly valves rated down to 1, 0.1 and below 0.1 µg/m³

In a split butterfly valve (SBV), a passive half is fitted to the mobile container and an active half to the process equipment; each half stays sealed until the two are docked, the two disc halves lock into one disc, and only then does the active unit open the valve for powder to pass, so the faces that were exposed to product are sealed against each other. [3] [4]

ChargePoint states that these figures were validated by customers and third parties to the ISPE SMEPAC guideline. [3] A ChargePoint author writing in Manufacturing Chemist places SBVs alongside isolators and rapid transfer ports for moving material from dispensing to granulation, blending, compression and coating, and notes that installation, condition, process and maintenance all affect the containment a valve achieves. [4]

Editorial note: compare the valve figure with the target from the section above. A valve stated down to 1 µg/m³ sits at the top of the Roche/Genentech OEB 3A range, and a compound with a 0.05 µg/m³ limit needs a better-rated valve or further controls around it.

For each transfer point, ask for the valve size, the containment figure with its SMEPAC test report, whether extraction is needed to reach it, and how the valve's use and wear are monitored.

03

Proving it with surrogate powder: lactose, acetaminophen or naproxen sodium, and why two reports can disagree

Containment performance is tested with a safe surrogate instead of the potent drug. A University of Hamburg and Fette Compacting study notes that ISPE recommends lactose, naproxen sodium or acetaminophen, and calls acetaminophen an industry-accepted standard for dustiness work because of its low HPLC quantification limit. [5] The ChargePoint author writes that “the most commonly used placebo is lactose”, because micronised grades are available and the guideline's suggested surrogates are APIs that general equipment workshops cannot handle. [4]

The same article lists what makes two SMEPAC reports diverge: the surrogate's particle size and bulk density; how test batches were dispensed and stored; the sampler model; whether only the filter or the filter and cassette were analysed; the powder mass — it asks whether a 100 mm device tested with 0.5 kg can be compared with one tested with 5 kg, both inside the guideline's range; and the number of runs, quoting the guideline that fewer than three runs leaves uncertainty. [4]

The Hamburg group found that changing how its test chamber was cleaned raised the amount of acetaminophen detected by more than ten times, and choosing the better-suited acetaminophen grade raised it by more than 25% again. [5] It also sets out which particles matter: airborne dust spans aerodynamic diameters up to 100 µm, particles under 10 µm can reach the thoracic region, deposition in the alveoli peaks around 2 µm, and particles under 0.5 µm are in its words “usually exhaled without being deposited”. [5]

Editorial note: ask for the full SMEPAC report — surrogate and grade, mass per transfer, sampler and analysis (filter only or filter plus cassette), number of runs and limit of detection — before comparing two suppliers' µg/m³ figures.

Specify the surrogate, transfer mass, number of runs and sampling positions for factory and site acceptance tests, and require the operator steps (docking, wiping, undocking) to be included in the test.

04

What to send for a potent-powder containment system

Paste it into your enquiry below or into an email to a maker, then replace every bracket.

Compound: [OEL or band range in µg/m³; banding scheme; 8-hour TWA]
Operations: [dispensing; charging the blender; sampling; discharge; cleaning]
Quantities: [kg per transfer; transfers per batch; container types]
Equipment: [isolator or enclosure; split valve sizes; extraction; filter stages]
Testing: [SMEPAC surrogate and grade; mass per run; number of runs; sampler; operator steps]
Documents: [containment test reports; maintenance and monitoring plan]

See manufacturer records Send an enquiry through CNFX